Mitochondrial aldehyde dehydrogenase (ALDH-2)-Maker of and marker for nitrate tolerance in response to nitroglycerin treatment

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 40-47

  Daiber, A ^a   Wenzel, P ^a   Oelze, M ^a   Schuhmacher, S ^a   Jansen, T ^a   Munzel T ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Bioactivation; Mitochondrial aldehyde dehydrogenase; Mitochondrial oxidative stress; Organic nitrate; Peroxynitrite; Superoxide; Vascular function

Indexed keywords

ALDEHYDE DEHYDROGENASE; CYCLIC GMP; CYCLOSPORIN A; DIAZOXIDE; DIHYDROLIPOATE; GLIBENCLAMIDE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; NITRATE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN SYNTHASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; ROTENONE;

ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; HUMAN; HYPERTENSION; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ALDEHYDE DEHYDROGENASE; DRUG TOLERANCE; HUMANS; MITOCHONDRIA; NITRATES; NITROGLYCERIN; OXIDATIVE STRESS;

EID: 59049099708     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.003     Document Type: Review

References (47)

1. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann. Intern. Med. 114 (1991) 667-677
2. Abrams J. A reappraisal of nitrate therapy. J. Am. Med. Assoc. 259 (1988) 396-401
3. Chung S.J., and Fung H.L. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J. Pharmacol. Exp. Ther. 253 2 (1990) 614-619
4. Dupuis J., Lalonde G., Lemieux R., and Rouleau J.L. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J. Am. Coll. Cardiol. 16 4 (1990) 923-931
5. Packer M., Lee W.H., Kessler P.D., Gottlieb S.S., Medina N., and Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N. Engl. J. Med. 317 13 (1987) 799-804
6. Parker J.D., Farrell B., Fenton T., Cohanim M., and Parker J.O. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84 6 (1991) 2336-2345
7. Molina C.R., Andresen J.W., Rapoport R.M., Waldman S., and Murad F. Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J. Cardiovasc. Pharm. 10 4 (1987) 371-378
8. Axelsson K.L., and Andersson R.G. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur. J. Pharmacol. 88 1 (1983) 71-79
9. Mulsch A., Busse R., and Bassenge E. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses. Eur. J. Pharmacol. 158 3 (1988) 191-198
10. Munzel T., Daiber A., and Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ. Res. 97 7 (2005) 618-628
11. Munzel T., Sayegh H., Freeman B.A., Tarpey M.M., and Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95 1 (1995) 187-194
12. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91 6 (1993) 2546-2551
13. Munzel T., Li H., Mollnau H., Hink U., Matheis E., Hartmann M., Oelze M., Skatchkov M., Warnholtz A., Duncker L., Meinertz T., and Forstermann U. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ. Res. 86 1 (2000) E7-E12
14. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., and Tarpey M.M. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1044-1048
15. Towell J., Garthwaite T., and Wang R. Erythrocyte aldehyde dehydrogenase and disulfiram-like side effects of hypoglycemics and antianginals. Alcohol. Clin. Exp. Res. 9 5 (1985) 438-442
16. Chen Z., Zhang J., and Stamler J.S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc. Natl. Acad. Sci. U.S.A. 99 12 (2002) 8306-8311
17. Chen Z., Foster M.W., Zhang J., Mao L., Rockman H.A., Kawamoto T., Kitagawa K., Nakayama K.I., Hess D.T., and Stamler J.S. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc. Natl. Acad. Sci. U.S.A. 102 34 (2005) 12159-12164
18. Wenzel P., Hink U., Oelze M., Seeling A., Isse T., Bruns K., Steinhoff L., Brandt M., Kleschyov A.L., Schulz E., Lange K., Weiner H., Lehmann J., Lackner K.J., Kawamoto T., Munzel T., and Daiber A. Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Br. J. Pharmacol. 150 (2007) 526-533
19. Sydow K., Daiber A., Oelze M., Chen Z., August M., Wendt M., Ullrich V., Mulsch A., Schulz E., Keaney Jr. J.F., Stamler J.S., and Munzel T. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J. Clin. Invest. 113 3 (2004) 482-489
20. Wenzel P., Hink U., Oelze M., Schuppan S., Schaeuble K., Schildknecht S., Ho K.K., Weiner H., Bachschmid M., Munzel T., and Daiber A. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity: implications for mitochondrial oxidative stress and nitrate tolerance. J. Biol. Chem. 282 1 (2007) 792-799
21. Chen Z., and Stamler J.S. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends Cardiovasc. Med. 16 8 (2006) 259-265
22. Daiber A., Oelze M., Coldewey M., Bachschmid M., Wenzel P., Sydow K., Wendt M., Kleschyov A.L., Stalleicken D., Ullrich V., Mulsch A., and Munzel T. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol. Pharmacol. 66 6 (2004) 1372-1382
23. Wenzel P., Hink U., Oelze M., Schuppan S., Schaeuble K., Schildknecht S., Ho K.K., Weiner H., Bachschmid M., Munzel T., and Daiber A. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J. Biol. Chem. 282 1 (2007) 792-799
24. Beretta M., Gruber K., Kollau A., Russwurm M., Koesling D., Goessler W., Keung W.M., Schmidt K., and Mayer B. Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases. J. Biol. Chem. 283 26 (2008) 17873-17880
25. Dudek M., Bednarski M., Bilska A., Iciek M., Sokolowska-Jezewicz M., Filipek B., and Wlodek L. The role of lipoic acid in prevention of nitroglycerin tolerance. Eur. J. Pharmacol. 591 1-3 (2008) 203-210
26. Daiber A., and Bachschmid M. Enzyme inhibition by peroxynitrite-mediated tyrosine nitration and thiol oxidation. Curr. Enzyme Inhib. 3 (2007) 103-117
27. Needleman P., and Hunter Jr. F.E. Effects of organic nitrates on mitochondrial respiration and swelling: possible correlations with the mechanism of pharmacologic action. Mol. Pharmacol. 2 2 (1966) 134-143
28. Jakschik B., and Needleman P. Sulfhydryl reactivity of organic nitrates: biochemical basis for inhibition of glyceraldehyde-P dehydrogenase and monoamine oxidase. Biochem. Biophys. Res. Commun. 53 2 (1973) 539-544
29. Needleman P., Jakschik B., and Johnson Jr. E.M. Sulfhydryl requirement for relaxation of vascular smooth muscle. J. Pharmacol. Exp. Ther. 187 2 (1973) 324-331
30. Daiber A., Oelze M., Coldewey M., Kaiser K., Huth C., Schildknecht S., Bachschmid M., Nazirisadeh Y., Ullrich V., Mulsch A., Munzel T., and Tsilimingas N. Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. Biochem. Biophys. Res. Commun. 338 4 (2005) 1865-1874
31. Hink U., Daiber A., Kayhan N., Trischler J., Kraatz C., Oelze M., Mollnau H., Wenzel P., Vahl C.F., Ho K.K., Weiner H., and Munzel T. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J. Am. Coll. Cardiol. 50 23 (2007) 2226-2232
32. Wenzel P., Oelze M., Coldewey M., Hortmann M., Seeling A., Hink U., Mollnau H., Stalleicken D., Weiner H., Lehmann J., Li H., Forstermann U., Munzel T., and Daiber A. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler. Thromb. Vasc. Biol. 27 8 (2007) 1729-1735
33. Daiber A., Oelze M., Sulyok S., Coldewey M., Schulz E., Treiber N., Hink U., Mulsch A., Scharffetter-Kochanek K., and Munzel T. Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD +/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol. Pharmacol. 68 3 (2005) 579-588
34. Wenzel P., Mollnau H., Oelze M., Schulz E., Wickramanayake J.M., Muller J., Schuhmacher S., Hortmann M., Baldus S., Gori T., Brandes R.P., Munzel T., and Daiber A. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal 10 8 (2008) 1435-1447
35. Doughan A.K., Harrison D.G., and Dikalov S.I. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102 4 (2008) 488-496
36. Wenzel P., Schuhmacher S., Kienhofer J., Muller J., Hortmann M., Oelze M., Schulz E., Treiber N., Kawamoto T., Scharffetter-Kochanek K., Munzel T., Burkle A., Bachschmid M.M., and Daiber A. MnSOD ALDH-2 deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc. Res. (2008) 10.1093/cvr/cvn182
37. Wenzel P., Muller J., Zurmeyer S., Schuhmacher S., Schulz E., Oelze M., Pautz A., Kawamoto T., Wojnowski L., Kleinert H., Munzel T., and Daiber A. ALDH-2 deficiency increases cardiovascular oxidative stress-Evidence for indirect antioxidative properties. Biochem. Biophys. Res. Commun. 367 1 (2008) 137-143
38. Szocs K., Lassegue B., Wenzel P., Wendt M., Daiber A., Oelze M., Meinertz T., Munzel T., and Baldus S. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. J. Mol. Cell. Cardiol. 42 6 (2007) 1111-1118
39. Nakamura Y., Moss A.J., Brown M.W., Kinoshita M., and Kawai C. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am. Heart J. 138 3 Pt 1 (1999) 577-585
40. Thomas G.R., DiFabio J.M., Tommaso T., and Parker J.D. Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free radical mediated mechanism. J. Am. Coll. Cardiol. 49 12 (2007) 1289-1295
41. Schulz E., Tsilimingas N., Rinze R., Reiter B., Wendt M., Oelze M., Woelken-Weckmuller S., Walter U., Reichenspurner H., Meinertz T., and Munzel T. Functional biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 105 10 (2002) 1170-1175
42. Mackenzie I.S., Maki-Petaja K.M., McEniery C.M., Bao Y.P., Wallace S.M., Cheriyan J., Monteith S., Brown M.J., and Wilkinson I.B. Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler. Thromb. Vasc. Biol. 25 9 (2005) 1891-1895
43. Li Y., Zhang D., Jin W., Shao C., Yan P., Xu C., Sheng H., Liu Y., Yu J., Xie Y., Zhao Y., Lu D., Nebert D.W., Harrison D.C., Huang W., and Jin L. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J. Clin. Invest. 116 2 (2006) 506-511
44. Huellner M.W., Schrepfer S., Weyand M., Weiner H., Wimplinger I., Eschenhagen T., and Rau T. Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins. FASEB J. 22 7 (2008) 2561-2568
45. Agarwal D.P., Cohn P., Goedde H.W., and Hempel J. Aldehyde dehydrogenase from human erythrocytes: structural relationship to the liver cytosolic isozyme. Enzyme 42 1 (1989) 47-52
46. Daiber A., August M., Baldus S., Wendt M., Oelze M., Sydow K., Kleschyov A.L., and Munzel T. Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. Free Radic. Biol. Med. 36 1 (2004) 101-111
47. Daiber A., Wenzel P., Oelze M., and Munzel T. New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin. Res. Cardiol. 97 1 (2008) 12-20